Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 448-050-6 | CAS number: 444065-11-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13 Aug - 19 Sep 2003
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP - guideline study with acceptable restrictions. The epicutaneous induction and challenge were performed under semi-occlusive conditions.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- epicutaneous induction and challenge performed under semi-occlusive conditions
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- epicutaneous induction and challenge performed under semi-occlusive conditions
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- epicutaneous induction and challenge performed under semi-occlusive conditions
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Agricuiture, Forestry and Fisheries (JMAFF), 12 Nousan, Notification No. 8147, November 2000, inciuding the most recent partial revisions
- Deviations:
- yes
- Remarks:
- epicutaneous induction and challenge performed under semi-occlusive conditions
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, Kisslegg, Germany
- Age at study initiation: approximately 4 weeks
- Weight at study initiation: 345-409 g (treatment group) and 369-415 g (control group)
- Housing: group housing of maximally 5 animals per labelled cage (74 cm x 54 cm x 25 cm height) containing purified sawdust as bedding material (SAWI, Jelu Werk, Rosenberg, Germany)
- Diet: standard guinea pig diet, including ascorbic acid (1000 mg/kg); (Charles River Breeding and Maintenance Diet for Guinea Pigs, Altromin, Lage, Germany), ad libitum. Pressed hay (B.M.l., Helmond, the Netherlands) was provided twice a week.
- Water: tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.0 ± 3.0 (actual range: 17.8-22.7 °C)
- Humidity (%): 30-70 (actual range: 45-89%)
- Air changes (per hr): approximately 15
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- intradermal and epicutaneous
- Vehicle:
- corn oil
- Concentration / amount:
- Intradermal induction: 0.5%
Epicutaneous induction: 50%
Challenge: 50% - Route:
- epicutaneous, semiocclusive
- Vehicle:
- corn oil
- Concentration / amount:
- Intradermal induction: 0.5%
Epicutaneous induction: 50%
Challenge: 50% - No. of animals per dose:
- 10 in treatment group
5 in control group - Details on study design:
- RANGE FINDING TESTS:
Prior to the start of the main study, the intradermal and epidermal irritancy of UC-141 was investigated to select test substance concentrations suitable for the induction and challenge phase of the main study. The selection was based on the absence of toxicity and on the following criteria for each route and/or study phase:
Induction (intradermal and epidermal): The highest possible concentration that produced moderate irritation (the intradermal reactions may include slight necrosis (< 3 mm in diameter)).
Challenge: The maximum non-irritant concentration.
A series of test substance concentrations were tested. The feasibility of administration determined the highest concentration for each route. The first and subsequent concentrations were selected from the series: 100% (undiluted), 50%, 20%, 10%, 5%, 2%, 1% and if needed, further lower concentrations using the same steps. The test system and procedures were identical to those used during the main study, unless otherwise specified. The four animals were 4-9 weeks old. No body weights were determined.
Intradermal Injections:
A series of four test substance concentrations was used; the highest concentration was the maximum concentration that could technically be
injected (5%). One animal received 2 and 5%, and the second animal received 0.5 and 1%, respectively, in duplicate (0.1 mL/site) in the clipped scapular region. The injection sites were assessed for irritation 24 and 48 hours after treatment. Slight erythema was observed atall 4 injection sites, 24 and 48 h after exposure. Injection of a 5%, 2% or 1% concentration was difficult and the reliability of the injected volume could not be established. Therefore, a 0.5% test substance concentration was considered the highest concentration that could reproducibly be injected.
Epidermal application:
A series of four test substance concentrations (5, 10, 20 and 50%) was used; the highest concentration being the maximum concentration that could technically be applied. Two different concentrations were applied (0.5 ml each) per animal to the clipped flank, using Metalline patches (2x3 cm) mounted on Medical tape , which were held in place with Micropore tape and subsequently Coban elastic bandage (all semi-occlusive covering). The animals receiving intradermal injections were treated with the lowest concentrations (5 and 10%) and two further animals with the highest concentrations (20 and 50%). After 24 hours, the dressing was removed and the skin cleaned of residual test substance. The treated skin areas were assessed for irritation 24 and 48 hours after exposure. No skin irritation was observed at any of the treated sites at any of the reading time points. As the epidermal induction using the test substance did not cause any skin irritation, the test site of all animals was treated with 10% SDS approximately 24 hours before the epidermal induction in the main study, to provoke a mild inflammatory reaction. A 50% solution was selected for the challenge phase in the main study.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2, intradermal and epicutaneous
- Exposure period: single injection (intradermal) and 48 hours (epicutaneous)
Intradermal, day 1 (3 pairs of injections, 0.1 mL/site):
Injection 1: a 1:1mixture (w/w) Freunds Complete Adjuvant (FCA)/water for injection
Injection 2: 0.5% (w/w) test substance in corn oil
Injection 3: 1% (w/w) test substance in a 1:1 mixture (w/w) with FCA
48 h after intradermal injection (day 3), the degree of erythema and edema was evaluated.
On day 7, the scapular area between the injection sites was clipped and subsequently rubbed with 10% sodium dodecyl sulfate (SDS, Boom, Meppel, the Netherlands) in vaseline using a spatula. This concentration of SDS provoked a mild inflammatory reaction.
Epicutaneous, day 8:
0.5 mL 50% (w/w) test substance in corn oil
The semi-occlusive dressing was kept in place for 48 h. The degree of erythema and edema was evaluated directly after cleaning the skin area with water (day 10).
- Control group:
Intradermal, day 1 (3 pairs of injections, 0.1 mL/site):
Injection 1: a 1:1 mixture (w/w) FCA/water
Injection 2: corn oil
Injection 3: corn oil, 50% (w/v) in a 1:1 mixture (w/w) FCA
On day 7, the scapular area between the injection sites was clipped and subsequently rubbed with 10% sodium-dodecyl-sulfate (SDS, Boom, Meppel, the Netherlands) in vaseline using a spatula. This concentration of SDS provoked a mild inflammatory reaction.
Epicutaneous, day 8: 0.5 mL corn oil
- Site: the shoulder region
- Frequency of applications: once (intradermal on day 1 and epicutaneous on day 8)
- Duration: day 1 (intradermal), day 8-10 (epicutaneous)
- Concentrations: 0.5% (intradermal), 50% (epicutaneous)
B. CHALLENGE EXPOSURE
- No. of exposures: 2 (challenge and rechallenge)
- Day(s) of challenge: 22 (challenge) and 29 (rechallenge)
- Exposure period: 24 hours
- Test groups: 0.1 mL test substance in corn oil
- Control group: 0.1 mL test substance in corn oil
- Site: approximately 20 mm x 30 mm, on one flank of the animals
- Concentration: 50%
- Evaluation (hr after challenge): 24 and 48 hours after the challenge ended - Positive control substance(s):
- yes
- Remarks:
- alpha-hexylcinnamicaldehyde, tech. 85%
- Positive control results:
- A reliability check is carried out at regular intervals with alpha-hexylcinnamic aldehyde to check the sensitivity of the test system and the reliability of the experimental methods used by the test laboratory. In an independent study performed in 2003, alpha-hexylcinnamic aldehyde induced sensitisation in 60% (6/10) of the Dunkin-Hartley guinea pigs challenged with a 20% solution. A 20% solution was used for intradermal induction and undiluted test substance was used for topical induction.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Scaling was observed in 4/10 guinea pigs
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: Scaling was observed in 4/10 guinea pigs.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- CLP: not classified
DSD: not classifed
24 h after intradermal induction, all test animals showed erythema on the injection sites. The concentration tested was 5% UC-141. However, the same effect was observed in all controls. Therefore, it is unclear whether the skin irritation was caused by the test substance itself or was a non-specific response to the injections. During the topical induction, 4/10 treated animals and 2/5 control animals had slight erythema on the test sites. Again, it is unclear whether the skin irritation was caused by the test substance or was a non-soecific response to the treatment. As no control animals showed sensitisation during the challenge and rechallenge, and no treated animals showed sensitisation reactions during the rechallenge, the test substance is not classified as sentitising.
Reference
There was no mortality, no signs of toxicity and no treatment-related effects on body weight.
24 hours after intradermal induction, slight to moderate erythema was noted at all of the injection sites of 10/10 treated and 5/5 control animals. Following the topical induction, slight erythema was noted at the test site in 4/10 treated animals and 2/5 control animals.
48 and 72 hours after the first challenge (day 22), no sensitisation was observed in the treated animals. At the 72 -hour reading time point, scaling was observed in 4/10 animals exposed to the test substance. This may have been and effect of the irritation caused by the skin irritation induced on day 1 and 8 of the study period. The animals were re-challenged one week after the first challenge (day 29). No sensitisation reactions were observed in the treated or control animals, 48 and 72 hours after re-challenge.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The skin sensitising potential of 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1 H-pyrrolo[1 ,2-b][1 ,2,4]triazole-7-carboxylic acid-2,6-di-tert-butyl-4-methyl-cyclohexyl ester (UC-141) was evaluated in a Guinea Pig Maximisation Test (GMPT) performed according to OECD 406 (Hooiveld, 2003).
The two induction phases were done by intradermal injection and topical application, respectively. The test animals were treated once (day 1) with 0.5% UC-141 including the adjuvants via three intradermal injections on each side of the mid-line during the first induction. All the animals were treated with 10% sodium dodecyl sulfate (SDS) on day 7, prior to the topical induction, to cause skin irritation. On day 8, 50% test substance (in corn oil) was applied with an occlusive dressing to the same skin sites for 48 hours. For the induction phases of the control animals, the test substance was omitted from the intradermal injections as well as the topical application. The animals were challenged with 50% UC-141 via topical application for 24 hours on day 22 and rechallenged under the same conditions on day 29.
24 hours after intradermal induction, slight to moderate erythema was noted at all the injection sites of 10/10 treated and 5/5 control animals. As all the animals had clear skin reactions after the intradermal induction this was a non-specific response to the injections. Following the topical induction, slight erythema was noted at the test site in 4/10 treated animals and 2/5 control animals, as expected after the SDS treatment. 48 hours after the first challenge (day 22), no skin effects were observed in the treated animals. At the 72 -hour reading time point, scaling was observed in 4/10 animals exposed to the test substance. No erythema or edema was observed. None of the control animals (0/5) showed signs of sensitisation at the 48 - and 72 -hour reading time points. The animals were rechallenged on day 29, due to the scaling observed after the first challenge. No sensitisation reactions were observed in the treated or control animals, 48 and 72 hours after re-challenge. As no control animals showed sensitisation during the challenge and rechallenge, and no treated animals showed sensitisation reactions during the rechallenge, the test substance is considered to be not sentitising. There was no mortality, no signs of toxicity and no treatment-related effects on body weight.
Migrated from Short description of key information:
Skin (OECD 406): not sensitising (Guinea pig maximisation test)
Justification for selection of skin sensitisation endpoint:
Only one study is available.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The available data on the skin sensitisation of the test substance do not meet the criteria for classification according to Regulation (EC) 1272/2008 or Directive 67/548/EEC, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.